Literature DB >> 23551349

Pilot study of pharmacological treatment for frontotemporal dementia: risk of donepezil treatment for behavioral and psychological symptoms.

Takemi Kimura, Junichi Takamatsu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23551349     DOI: 10.1111/j.1447-0594.2012.00956.x

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


× No keyword cloud information.
  10 in total

1.  Treatment of frontotemporal dementia.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

Review 2.  Therapy and clinical trials in frontotemporal dementia: past, present, and future.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

Review 3.  Frontotemporal Dementia.

Authors:  Nicholas T Olney; Salvatore Spina; Bruce L Miller
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

Review 4.  Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments.

Authors:  Fleur Harrison; Liesbeth Aerts; Henry Brodaty
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

Review 5.  Behavioral Variant Frontotemporal Dementia.

Authors:  Bradley F Boeve
Journal:  Continuum (Minneap Minn)       Date:  2022-06-01

6.  Diagnosis and treatment of corticobasal degeneration.

Authors:  Melissa J Armstrong
Journal:  Curr Treat Options Neurol       Date:  2014-03       Impact factor: 3.598

7.  The influence and changes in the dosages of concomitantly used psychotropic drugs associated with the discontinuation of donepezil in severe Alzheimer's disease with behavioral and psychological symptoms on dementia: a preliminary open-label trial.

Authors:  Hidenobu Suzuki; Yuichi Inoue; Katsunaka Mikami; Keishi Gen
Journal:  Ther Adv Psychopharmacol       Date:  2014-02

8.  Two cases of Alzheimer's disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil.

Authors:  Takemi Kimura; Junichi Takamatsu
Journal:  Neuropsychiatr Dis Treat       Date:  2012-12-28       Impact factor: 2.570

Review 9.  Four-Repeat Tauopathies: Current Management and Future Treatments.

Authors:  Lawren VandeVrede; Peter A Ljubenkov; Julio C Rojas; Ariane E Welch; Adam L Boxer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

10.  Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia.

Authors:  Helen Shiells; Bjoern O Schelter; Peter Bentham; Thomas C Baddeley; Christopher M Rubino; Harish Ganesan; Jeffrey Hammel; Vesna Vuksanovic; Roger T Staff; Alison D Murray; Luc Bracoud; Damon J Wischik; Gernot Riedel; Serge Gauthier; Jianping Jia; Hans J Moebius; Jiri Hardlund; Christopher M Kipps; Karin Kook; John M D Storey; Charles R Harrington; Claude M Wischik
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.